Document is current
Any future updates will be listed below
-
Authors
Alexander, Sarah M.
Agaba, Alfred
Campbell, Jeffrey I.
Nambogo, Nuriat
Camlin, Carol S.
Johnson, Mallory
Dorsey, Grant
Olson, Kristian R.
Bangsberg, David R.
Carroll, Ryan W.
Santorino, Data
Krezanoski, Paul J.
-
Funding
Funding for this research was provided by:
Center for Global Health, Massachusetts General Hospital
Thrasher Research Fund, Early Career Award
Consortium for Affordable Medical Technologies
National Institute of Allergy and Infectious Diseases (K23AI139364)
Opportunity Solutions International
- License Information
-
More Information
Article History
Received: 9 November 2021
Accepted: 6 May 2022
First Online: 19 May 2022
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations including the Declaration of Helsinki. Study procedures were approved by Institutional Review Boards at the Mbarara University of Science and Technology in Uganda and Partners Healthcare in the United States, with additional approval given by the Uganda National Council for Science and Technology. Furthermore, written informed consent was obtained from all subjects in this manuscript.
: Not applicable.
: SmartNet was invented by PJK. who, along with Massachusetts General Hospital (which funded part of this work), co-owns intellectual property in SmartNet. PJK. is a co-founder and director (unpaid) of Opportunity Solutions International (ExternalRef removed) a 501(c)3 nonprofit organization which also funded part of this work. All other authors have no competing interests to declare.
